CSI Market
Sign In | Register

Marizyme Inc (MARZ) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MARZ quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Marizyme Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Operating Activities
Income-69.54
Depreciation & amortization0.84
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.19
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.53
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt19.61
Professional Fees-
Stock Issued During Period Value Issued For Services-
Stock Based Compensation-
Issuance Of Common Stock For Services-
Stockbased Compensation Restricted Common Stock-
Interest And Accretion Expenses13.25
Issuance Of Warrants For Services9.08
Loss On Issuance Of Debt6.89
Shares Issued As Part Of Confidential Settlement Agreement0.15
Shares Issued For Services0.17
Depreciation Depletion And Amortization-
Operating Lease Right Of Use Asset Amortization Expense-4.30
Shares Issued For Legal Settlement-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables0.01
Accounts Payable0.23
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.43
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities17.77
Discontinued operations0.00
Net Cash flow from Operating Activities-4.68
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Writedown Goodwill And Intangibles-
Proceeds From Sale Of Subsidiaries-
Write Down Goodwil L Andi Ntangibles-
Goodwill And Intangible Asset Impairment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net1.38
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.16
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.11
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Debt Instrument Decrease Forgiveness-
Proceeds From Promissory Notes Due To Related Parties-
Proceeds From Notes Payable Related Parties-
Proceeds From Financing Net Of Issuance Cost-
Proceeds From Financing Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.32
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.68
Total Cash Flow-0.36
4 historic quarters locked

Sign in to unlock the full Marizyme Inc cash flow history.

Sign In Create Free Account

About Marizyme Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: May 13, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-018935

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License